CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 189 enrolled
Drug / intervention
Dutasteride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01758523
NCT01758523Phase 4Completed
CompareCT.gov

Dutasteride Treatment for the Reduction of Heavy Drinking

UConn Health·interventional·Posted Jan 1, 2013·Updated Apr 26, 2019

In Brief

A Phase 4 clinical trial evaluating Dutasteride and sugar pill for Alcoholism and 2 related conditions. Completed, enrolled 189 participants across 1 site.

Detailed Summary

This study will examine the safety and potential benefit of the medication dutasteride to help men reduce or stop drinking alcohol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholism, Alcohol Abuse, Alcohol Dependence
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 1, 2013
Enrollment StartJan 1, 2013
Primary CompletionFeb 28, 2018
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 13.5 years ago

Interventions

Dutasteridedrug

sugar pilldrug